gamma-aminobutyric acid has been researched along with Brown Tendon Sheath Syndrome in 7 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Excerpt | Relevance | Reference |
---|---|---|
"We report two cases of unusual movement disorders associated with the use of gabapentin (GBP) in patients being treated for epilepsy who were otherwise neurologically intact." | 3.69 | Movement disorders associated with the use of gabapentin. ( Krahn, LE; Reeves, AL; Sharbrough, FW; So, EL, 1996) |
"Acquired brain injury can cause eye movement disorders which may include: strabismus, gaze deficits and nystagmus, causing visual symptoms of double, blurred or 'juddery' vision and reading difficulties." | 2.58 | Interventions for eye movement disorders due to acquired brain injury. ( Dodridge, CS; Evans, JR; Garcia-Finana, M; Hanna, K; Howard, C; Jarvis, KA; Maan, T; MacDiarmid, SL; Noonan, CP; North, L; Rodgers, H; Rowe, FJ, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rowe, FJ | 1 |
Hanna, K | 1 |
Evans, JR | 1 |
Noonan, CP | 1 |
Garcia-Finana, M | 1 |
Dodridge, CS | 1 |
Howard, C | 1 |
Jarvis, KA | 1 |
MacDiarmid, SL | 1 |
Maan, T | 1 |
North, L | 1 |
Rodgers, H | 1 |
Hounnou, P | 1 |
Nicoucar, K | 1 |
Oskarsson, B | 1 |
Pelak, V | 1 |
Quan, D | 1 |
Hall, D | 1 |
Foster, C | 1 |
Galetta, S | 1 |
Pistoia, F | 1 |
SarĂ , M | 1 |
Economides, JR | 1 |
Horton, JC | 1 |
Reeves, AL | 1 |
So, EL | 1 |
Sharbrough, FW | 1 |
Krahn, LE | 1 |
Leigh, RJ | 1 |
Ramat, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Examining the Effect of Eye Gaze Technology on Children With Cortical Visual Impairment and Its Impact on Occupational Performance[NCT06067607] | 10 participants (Anticipated) | Interventional | 2023-02-01 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for gamma-aminobutyric acid and Brown Tendon Sheath Syndrome
Article | Year |
---|---|
Interventions for eye movement disorders due to acquired brain injury.
Topics: 4-Aminopyridine; Abducens Nerve Diseases; Amifampridine; Amines; Baclofen; Botulinum Toxins; Brain I | 2018 |
Neuropharmacologic aspects of the ocular motor system and the treatment of abnormal eye movements.
Topics: Abducens Nerve; Acetates; Amines; Baclofen; Cranial Nerve Diseases; Cyclohexanecarboxylic Acids; Eye | 1999 |
5 other studies available for gamma-aminobutyric acid and Brown Tendon Sheath Syndrome
Article | Year |
---|---|
Delayed onset of rotatory self-motion perception, dysdiadochokinesia and disturbed eye pursuit caused by low-dose pregabalin.
Topics: Adult; Analgesics; Cerebellar Ataxia; Chronic Pain; Female; gamma-Aminobutyric Acid; Humans; Ocular | 2014 |
Stiff eyes in stiff-person syndrome.
Topics: Autoantibodies; Diagnosis, Differential; Disease Progression; Electromyography; Female; gamma-Aminob | 2008 |
Gabapentin therapy for ocular opsoclonus-myoclonus restores eye movement communication in a patient with a locked-in syndrome.
Topics: Adult; Amines; Anticonvulsants; Cerebral Infarction; Cyclohexanecarboxylic Acids; Female; Gabapentin | 2010 |
Eye movement abnormalities in stiff person syndrome.
Topics: Adult; Atrophy; Brain Stem; Cerebellar Diseases; Cerebellum; Female; gamma-Aminobutyric Acid; Glutam | 2005 |
Movement disorders associated with the use of gabapentin.
Topics: Acetates; Adult; Amines; Anticonvulsants; Benzodiazepines; Cyclohexanecarboxylic Acids; Dyskinesia, | 1996 |